---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-013944"
form_type: "8-K"
ticker: "MTVA"
cik: "0001638287"
company_name: "MetaVia Inc."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T02:09:27.502357+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NeuroBo gets 180-day Nasdaq bid-price extension to Feb 5, 2024; still below $1.00

## Summary
- Nasdaq granted 180-day extension to Feb 5, 2024 to regain $1.00 minimum bid price.
- Stockholders approved reverse stock split (1:5 to 1:8) on June 28, 2023; board may implement.
- If not compliant by Feb 5, 2024, Nasdaq will issue delisting notice; company can appeal.
- Updated risk factors highlight potential delisting impact on liquidity and capital raising.

## SEC filing metadata
- accession: 0001558370-23-013944
- form_type: 8-K
- ticker: MTVA
- cik: 0001638287
- company_name: MetaVia Inc.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638287/000155837023013944/0001558370-23-013944-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638287/000155837023013944/nrbo-20230808x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-013944
- JSON: https://secwatch.observer/filing/0001558370-23-013944.json
- Plain text: https://secwatch.observer/filing/0001558370-23-013944.txt

## Key facts
- Listing & Compliance Notices
  MetaVia Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: February 8, 2023, NeuroBo Pharmaceuticals, Inc. (the “Company” ) received a letter (the “Notice” ) from the Listing Qualifications Department (the “Staff” ) of the Nasdaq Stock Market ( “Nasdaq” ) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement” ). In accordance with Nasdaq Listing Rule
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638287/000155837023013944/0001558370-23-013944-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.